Lifeline Biotechnologies Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2004	FY 2003	FY 2002
Period Ending	Dec '04 Dec 31, 2004	Dec '03 Dec 31, 2003	Dec '02 Dec 31, 2002
Net Income	-1.74	-0.85	-0.86
Depreciation & Amortization	0.06	0.05	0.05
Loss (Gain) From Sale of Assets	-	-0.22	-
Asset Writedown & Restructuring Costs	0.04	0.11	-
Stock-Based Compensation	0.25	0.3	-
Other Operating Activities	-	0.03	-
Change in Inventory	-0.22	-0.11	-
Change in Accounts Payable	-0.03	0.07	-0.06
Change in Other Net Operating Assets	0	0.49	-
Operating Cash Flow	-1.63	-0.13	-0.86
Capital Expenditures	-0.04	-0.01	-0.02
Divestitures	-	-	0.02
Sale (Purchase) of Intangibles	-0.12	-0.05	-
Other Investing Activities	-	-0.56	-
Investing Cash Flow	-0.16	-0.63	0
Short-Term Debt Issued	0.1	0.02	-
Long-Term Debt Issued	0.4	0.03	0.04
Total Debt Issued	0.5	0.05	0.04
Long-Term Debt Repaid	-0	-0.15	-
Net Debt Issued (Repaid)	0.5	-0.1	0.04
Issuance of Common Stock	0.67	0.98	0.76
Other Financing Activities	0.56	0.12	-
Financing Cash Flow	1.73	1	0.8
Net Cash Flow	-0.06	0.24	-0.05
Free Cash Flow	-1.67	-0.14	-0.88
Free Cash Flow Margin	-1689.68%	-496.85%	-
Levered Free Cash Flow	-0.53	-	-
Unlevered Free Cash Flow	-0.53	-	-
Change in Working Capital	-0.24	0.46	-0.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.